The U.S. Supreme Court has ruled for a drug company fighting generic competitors in a decision on the proper standard of review in patent infringement cases involving factual issues. In a 7-2 decision (PDF), the Supreme Court held that factual conclusions by trial judges in claim construction cases should be…
Jan 20, 2015 10:45 AM CST